Published in Biochem Biophys Res Commun on February 09, 2001
Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A (2007) 1.98
Dietary salt regulates epithelial sodium channels in rat endothelial cells: adaptation of vasculature to salt. Br J Pharmacol (2015) 1.46
Salt overload damages the glycocalyx sodium barrier of vascular endothelium. Pflugers Arch (2011) 1.19
Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. Br J Pharmacol (2009) 1.18
Aldosterone and amiloride alter ENaC abundance in vascular endothelium. Pflugers Arch (2007) 1.13
Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol (2010) 1.05
The role of ENaC in vascular endothelium. Pflugers Arch (2013) 0.94
Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells. Nat Rev Nephrol (2014) 0.94
Endothelial cell swelling by aldosterone. J Membr Biol (2003) 0.93
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation. J Biol Chem (2009) 0.92
Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications. Br J Pharmacol (2013) 0.92
Two barriers for sodium in vascular endothelium? Ann Med (2012) 0.89
Is the vascular endothelium under the control of aldosterone? Facts and hypothesis. Pflugers Arch (2007) 0.89
Role of the epithelial sodium channel in salt-sensitive hypertension. Acta Pharmacol Sin (2011) 0.88
Feedforward activation of endothelial ENaC by high sodium. FASEB J (2014) 0.87
Nanomechanics of vascular endothelium. Cell Tissue Res (2014) 0.86
Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney. Hypertension (2013) 0.85
A physiological concept unmasking vascular salt sensitivity in man. Pflugers Arch (2012) 0.80
An emerging concept of vascular salt sensitivity. F1000 Biol Rep (2012) 0.79
How steroid hormones act on the endothelium--insights by atomic force microscopy. Pflugers Arch (2008) 0.77
Intracellular calcium: a prerequisite for aldosterone action. J Membr Biol (2003) 0.77
Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury. J Pharmacol Exp Ther (2015) 0.76
Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone. Biomed Res Int (2015) 0.75
AMP-Activated Protein Kinase Attenuates High Salt-Induced Activation of Epithelial Sodium Channels (ENaC) in Human Umbilical Vein Endothelial Cells. Oxid Med Cell Longev (2016) 0.75
The endothelial αENaC contributes to vascular endothelial function in vivo. PLoS One (2017) 0.75
Nuclear envelope: nanoarray responsive to aldosterone. J Membr Biol (2004) 0.75
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
NDT80, a meiosis-specific gene required for exit from pachytene in Saccharomyces cerevisiae. Mol Cell Biol (1995) 3.82
Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation (1999) 3.44
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat Cell Biol (2001) 2.91
Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation (2000) 2.49
The DYT1 phenotype and guidelines for diagnostic testing. Neurology (2000) 2.39
A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation--PROTECT. Am J Transplant (2012) 2.24
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology (2002) 1.90
The UV response involving the Ras signaling pathway and AP-1 transcription factors is conserved between yeast and mammals. Cell (1994) 1.85
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
The 'essentials' of essential palatal tremor: a reappraisal of the nosology. Brain (2005) 1.78
alpha-Synuclein and Parkinson disease susceptibility. Neurology (2007) 1.72
Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry (2009) 1.70
Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol (1999) 1.67
Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype. Neurology (2008) 1.60
Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol (2003) 1.56
Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Neuropediatrics (2007) 1.52
Neurosurgical intervention for cervical disk disease in dystonic cerebral palsy. Mov Disord (1998) 1.51
Long-term fecal excretion and resistance induced in mice infected with Yersinia enterocolitica. Infect Immun (1978) 1.47
Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem (1999) 1.45
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42
Evidence for linkage of restless legs syndrome to chromosome 9p: are there two distinct loci? Neurology (2007) 1.42
Urinary incontinence. Not a 'normal' part of aging. Postgrad Med (1991) 1.40
Parkinson's disease in twins: a follow-up study. Neurology (1999) 1.40
Degradable bisphosphonate-alkaline phosphatase-complexed hydroxyapatite implants in vitro. J Bone Miner Res (1997) 1.40
Treatment of ABO hemolytic disease with synthetic blood group trisaccharides. Vox Sang (1994) 1.40
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
[Treatment of sialorrhea with botulinum toxin: an overview]. Nervenarzt (2005) 1.38
The effect of halothane on the recirculatory pharmacokinetics of physiologic markers. Anesthesiology (1997) 1.38
High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening. Neurology (2005) 1.34
Induction of phosphodiesterase by cyclic adenosine 3':5'-monophosphate in differentiating Dictyostelium discoideum amoebae. J Biol Chem (1975) 1.33
Studies on the effect of cortisone on rat liver transfer ribonucleic acid. Biochemistry (1969) 1.33
Fate of virus DNA in the abortive infection of human lymphoid cell lines by Epstein-Barr virus. J Gen Virol (1972) 1.33
Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology (2002) 1.32
Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology (1999) 1.31
Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53. Biochemistry (2001) 1.30
In vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion. Circulation (2004) 1.29
Adenylate cyclase activity in Dictyostelium discoideum amoebae and its changes during differentiation. FEBS Lett (1976) 1.27
Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency. J Neurol Neurosurg Psychiatry (2006) 1.27
cAMP,-induced changes in cAMP-binding sites on D; discoideum amebae. Cell (1977) 1.26
Transoral decompression, anterior plate fixation, and posterior wire fusion for irreducible atlantoaxial kyphosis in rheumatoid arthritis. Spine (Phila Pa 1976) (2000) 1.26
Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology (2001) 1.25
Tumor necrosis factor-alpha-induced adipose-related protein (TIARP), a cell-surface protein that is highly induced by tumor necrosis factor-alpha and adipose conversion. J Biol Chem (2001) 1.22
Growth phase-dependent regulation and membrane localization of SpaB, a protein involved in biosynthesis of the lantibiotic subtilin. Appl Environ Microbiol (1994) 1.21
Clinical findings of a myoclonus-dystonia family with two distinct mutations. Neurology (2002) 1.20
Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. Exp Neurol (2009) 1.19
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics (2001) 1.18
Further characterization of a type III secretion system (T3SS) and of a new effector protein from a clinical isolate of Aeromonas hydrophila--part I. Microb Pathog (2007) 1.18
Revision of the validity of CAMP tests for Listeria identification. Proposal of an alternative method for the determination of haemolytic activity by Listeria strains. Acta Microbiol Hung (1990) 1.18
Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain (2005) 1.18
Phenotypic features of myoclonus-dystonia in three kindreds. Neurology (2002) 1.17
Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation (2003) 1.16
Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology (2004) 1.15
Modifications of ribonucleic acid by chemical carcinogens. II. In vivo reaction of N-2-acetylaminofluorene with rat liver ribonucleic acid. Biochemistry (1970) 1.14
Purification and characterization of two Listeria ivanovii cytolysins, a sphingomyelinase C and a thiol-activated toxin (ivanolysin O). Infect Immun (1989) 1.12
Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology (2002) 1.12
Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology (2007) 1.12
cAMP induces a rapid and reversible modification of the chemotactic receptor in Dictyostelium discoideum. J Cell Biol (1985) 1.11
Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat (2008) 1.10
Mediators of inflammation and acute phase response in the liver. Cell Mol Biol (Noisy-le-grand) (2001) 1.10
New challenges for informed consent through whole genome array testing. J Med Genet (2009) 1.10
Quality assurance for pharmacy-prepared sterile products in hospitals and home infusion facilities. Am J Health Syst Pharm (1996) 1.10
Effects of cyclic AMP pulses on adenylate cyclase and the phosphodiesterase inhibitor of D. discoideum. Nature (1977) 1.09
Physical and functional heterogeneity in TYMV RNA: evidence for the existence of an independent messenger coding for coat protein. Nucleic Acids Res (1976) 1.09
S-antigen immunoreactivity in retinal rods and cones and pineal photosensitive cells. Biol Cell (1984) 1.09
Streptozotocin: mechanisms of action: proceedings of a workshop held on 21 June 1980, Washington, DC. FEBS Lett (1980) 1.09
Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod (2000) 1.09
Involvement of calcium and calmodulin in Toxoplasma gondii tachyzoite invasion. Eur J Cell Biol (1997) 1.08
Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet (2001) 1.08
Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol (2001) 1.08
Live fish in right bronchus. J Otolaryngol (1978) 1.08
Topographic organization of the ventral striatal efferent projections in the rhesus monkey: an anterograde tracing study. J Comp Neurol (1990) 1.08
Electron tomography of metaphase nucleolar organizer regions: evidence for a twisted-loop organization. Mol Biol Cell (1997) 1.08
The relationship of phosphodiesterase to the developmental cycle of Dictyostelium discoideum. Biochem Biophys Res Commun (1975) 1.08
Influence of carbon tetrachloride on inducible liver enzymes and response to endotoxin in mice. J Bacteriol (1967) 1.07
Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J Natl Cancer Inst (1995) 1.07
Arrhythmogenic effects of orally administered bronchodilators. Arch Intern Med (1979) 1.07
Nasal, pharyngeal, and laryngeal manifestations of hypothyroidism. Ear Nose Throat J (1977) 1.07
Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology (2002) 1.07
Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett (2001) 1.06
Vasculogenic mimicry of acute leukemic bone marrow stromal cells. Leukemia (2009) 1.06
German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations. Parkinsonism Relat Disord (1997) 1.06
The TOR1A (DYT1) gene family and its role in early onset torsion dystonia. Genomics (1999) 1.05
Gender differences in problem severity at assessment and treatment retention. J Subst Abuse Treat (2001) 1.05
The function of the periplasmic Sud protein in polysulfide respiration of Wolinella succinogenes. Eur J Biochem (1998) 1.05
The German national registry for primary immunodeficiencies (PID). Clin Exp Immunol (2013) 1.05
Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol (2000) 1.04
Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology (2007) 1.04
An immunochemical method to measure atmospheric allergens. J Allergy Clin Immunol (1981) 1.04
Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology (2008) 1.03
Monoclonal antibodies: use to detect developmentally regulated antigens on D. discoideum amebae. Cell (1983) 1.03
Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. Eur J Radiol (2007) 1.03
Molecular typing by pulsed-field gel electrophoresis of Spanish animal and human Listeria monocytogenes isolates. Appl Environ Microbiol (2001) 1.02
Yeast signal peptidase contains a glycoprotein and the Sec11 gene product. Proc Natl Acad Sci U S A (1991) 1.02